کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2107460 | 1083678 | 2010 | 12 صفحه PDF | دانلود رایگان |

SummaryLung cancer is the leading cause of cancer-related deaths in the world, and non-small-cell lung cancer (NSCLC) accounts for 80% of cases. MicroRNA-21 (miR-21) expression is increased and predicts poor survival in NSCLC. Although miR-21 function has been studied in vitro with cancer cell lines, the role of miR-21 in tumor development in vivo is unknown. We utilize transgenic mice with loss-of-function and gain-of-function miR-21 alleles combined with a model of NSCLC to determine the role of miR-21 in lung cancer. We show that overexpression of miR-21 enhances tumorigenesis and that genetic deletion of miR-21 partially protects against tumor formation. MiR-21 drives tumorigenesis through inhibition of negative regulators of the Ras/MEK/ERK pathway and inhibition of apoptosis.
Graphical AbstractFigure optionsDownload high-quality image (68 K)Download as PowerPoint slideHighlights
► miR-21 overexpression promotes tumorigenesis in a mouse model of NSCLC
► miR-21 deletion suppresses tumorigenesis in a mouse model of NSCLC
► miR-21 targets multiple suppressors of Ras signaling enhancing proliferation
► miR-21 suppresses apoptosis by targeting proapoptotic genes enhancing survival
Journal: - Volume 18, Issue 3, 14 September 2010, Pages 282–293